SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-10-001552
Filing Date
2010-05-14
Accepted
2010-05-14 14:29:08
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT slxcf_10q.htm 10-Q 573907
2 CERTIFICATION slxcf_ex311.htm EX-31.1 14375
3 CERTIFICATION slxcf_ex312.htm EX-31.2 14393
4 CERTIFICATION slxcf_ex321.htm EX-32.1 5773
5 CERTIFICATION slxcf_ex322.htm EX-32.2 6167
  Complete submission text file 0001354488-10-001552.txt   616064
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 10832450
SIC: 2834 Pharmaceutical Preparations